Evidence map›Paper›PMID 41708763›Full record

ArticleScientific reports2026

Addressing the balance between fairness and performance in glioma grade prediction using bias mitigation techniques.

Raquel Sánchez-Marqués, Vicente García, J Salvador Sánchez

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Raquel Sánchez-MarquésCentre on Climate Change and Planetary Health, MRC Unit The Gambia at London School of Hygiene and Tropical Medicine, Fajara, The Gambia.
Vicente GarcíaDept. Electrical and Computer Engineering, Instituto de Ingeniería y Tecnología, Universidad Autónoma de Ciudad Juárez, Ciudad Juárez, 32310, Mexico.
J Salvador SánchezDept. Computer Languages and Systems, Institute of New Imaging Technologies, Universitat Jaume I, Castelló de la, Plana, 12071, Spain. sanchez@uji.es.

Funding

Generalitat Valenciana CAICO/2023/032
6 · The paper itself

Abstract

This research paper investigates the impact of demographic biases, specifically race and gender, on machine learning-based glioma grading, using the TCGA data set compiled from The Cancer Genome Atlas. The study applies three common classifiers (logistic regression, random forests, and extreme gradient boosting) and explores pre-processing (reweighting) and post-processing (equalized odds) strategies for bias mitigation. It evaluates prediction performance metrics (Matthews correlation coefficient, recall, specificity) and fairness metrics (disparate impact, equal opportunity difference, error rate difference), highlighting the trade-offs between fairness and accuracy across different demographic groups. For the most severe bias (race), the pre-trained logistic regression model using the reweighting algorithm shows some deterioration in prediction outcomes for the under-represented group and even an increase in unfairness, while the post-processing approach improves results for the under-represented group and provides significant improvements in fairness. These results are interesting because they could be taken into account in real-world clinical decision-making or in outcomes for under-represented patient groups.

Indexed as

Brain NeoplasmsGliomaBiasBoosting Machine Learning AlgorithmsClassification AlgorithmsFemaleHumansLogistic ModelsMachine LearningMaleNeoplasm GradingPrediction AlgorithmsPredictive Learning ModelsRandom ForestBiasDebiasingFairnessGliomaMachine learningPerformance

Identifiers

PMID41708763
PMCPMC13013607

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.